Avanos MedicalAVNS
紐約證券 · USD
24.98
-0.05
(-0.20%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
Avanos MedicalAVNS
24.98
-0.05
(-0.20%)
財務數據
損益表
- 1.73
- 1.66
- 1.72
- 1.70
- 1.80
- 1.68
- 1.75
- 1.78
- 1.81
- 1.82
- 1.17
- -4.15
- 3.37
- -0.76
- 5.40
- -6.74
- 4.48
- 1.60
- 1.74
- 0.72
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 182,200 | 180,900 | 177,800 | 175,000 | 167,500 | 179,600 | 170,400 | 171,700 | 166,100 | 173,300 |
營業成本 | 88,000 | 94,900 | 91,800 | 82,900 | 77,700 | 81,600 | 77,500 | 76,100 | 71,300 | 78,300 |
營業毛利 | 94,200 | 86,000 | 86,000 | 92,100 | 89,800 | 98,000 | 92,900 | 95,600 | 94,800 | 95,000 |
營業費用 | 85,300 | 83,500 | 85,900 | 166,600 | 79,500 | 516,500 | 80,900 | - | - | 83,800 |
研發費用 | 5,200 | 6,100 | 6,000 | 5,800 | 5,400 | 5,700 | 7,200 | 6,300 | 7,000 | 6,800 |
推銷及管理費用 | 80,100 | 77,400 | 79,900 | 83,800 | 74,100 | 74,100 | 73,700 | 83,000 | 83,800 | 77,000 |
非經常性項目費用 | - | - | - | 77,000 | - | 436,700 | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 8,900 | 2,500 | 100 | -74,500 | 10,300 | -418,500 | 12,000 | 6,300 | 4,000 | 11,200 |
其他收入及費用 | 200 | 600 | 500 | 600 | 1,500 | 800 | 700 | 3,000 | 600 | 1,000 |
利息費用 | 1,500 | 1,900 | 1,800 | 2,000 | 2,100 | 2,800 | 3,200 | 3,100 | 3,100 | 3,300 |
稅前純益 | 7,600 | 1,200 | -1,200 | -75,900 | 9,700 | -420,500 | 9,500 | 6,200 | 1,500 | 8,900 |
所得稅 | 2,500 | 2,500 | 200 | 900 | 3,100 | -23,500 | 3,600 | 1,900 | 1,000 | -2,100 |
稅後純益 | 5,100 | -1,300 | -1,400 | -76,800 | 6,600 | -397,300 | 4,300 | 1,800 | -900 | 10,500 |
基本每股稅後盈餘(元) | 0.11 | -0.02 | -0.03 | -1.66 | 0.14 | -8.64 | 0.10 | 0.04 | -0.02 | 0.23 |
稀釋每股稅後盈餘(元) | 0.11 | -0.02 | -0.03 | -1.66 | 0.14 | -8.64 | 0.09 | 0.04 | -0.02 | 0.23 |
基本平均股數(千股) | 46500.00 | 46400.00 | 46400.00 | 46300.00 | 46100.00 | 46000.00 | 46000.00 | 45900.00 | 46200.00 | 46200.00 |
稀釋平均股數(千股) | 47500.00 | 45800.00 | 46400.00 | 46300.00 | 46800.00 | 46000.00 | 46600.00 | 46300.00 | 46700.00 | 46600.00 |
還原基本每股稅後盈餘(元) | 0.11 | -0.02 | -0.03 | -1.66 | 0.14 | -8.64 | 0.10 | 0.04 | -0.02 | 0.23 |
還原稀釋每股稅後盈餘(元) | 0.11 | -0.02 | -0.03 | -1.66 | 0.14 | -8.64 | 0.09 | 0.04 | -0.02 | 0.23 |
還原基本平均股數(千股) | 46,500 | 46,400 | 46,400 | 46,300 | 46,100 | 46,000 | 46,000 | 45,900 | 46,200 | 46,200 |
還原稀釋平均股數(千股) | 47,500 | 45,800 | 46,400 | 46,300 | 46,800 | 46,000 | 46,600 | 46,300 | 46,700 | 46,600 |
EBITDA(千元) | 19,300 | 13,000 | 10,000 | -63,900 | 21,400 | -406,900 | 22,800 | 18,100 | 14,600 | 23,200 |